Mitochondrial Replacement Techniques
Ethical, Social, and Policy Considerations
Seiten
2016
National Academies Press (Verlag)
978-0-309-38870-2 (ISBN)
National Academies Press (Verlag)
978-0-309-38870-2 (ISBN)
Mitochondrial replacement techniques (MRTs) are designed to prevent the transmission of mitochondrial DNA (mtDNA) diseases from mother to child. While MRTs, if effective, could satisfy a desire of women seeking to have a genetically related child without the risk of passing on mtDNA disease, the technique raises significant ethical and social issues. It would create offspring who have genetic material from two women, something never sanctioned in humans, and would create mitochondrial changes that could be heritable (in female offspring), and therefore passed on in perpetuity. The manipulation would be performed on eggs or embryos, would affect every cell of the resulting individual, and once carried out this genetic manipulation is not reversible.
Mitochondrial Replacement Techniques considers the implications of manipulating mitochondrial content both in children born to women as a result of participating in these studies and in descendants of any female offspring. This study examines the ethical and social issues related to MRTs, outlines principles that would provide a framework and foundation for oversight of MRTs, and develops recommendations to inform the Food and Drug Administration's consideration of investigational new drug applications.
Table of Contents
Front Matter
Summary
1 Introduction
2 Science and Policy Context
3 Do Ethical, Social, and Policy Considerations Preclude MRT?
4 Regulation and Oversight of MRT in Humans
Appendix A: Study Approach
Appendix B: Summary of MRT Research
Appendix C: Biosketches of Committee Members
Mitochondrial Replacement Techniques considers the implications of manipulating mitochondrial content both in children born to women as a result of participating in these studies and in descendants of any female offspring. This study examines the ethical and social issues related to MRTs, outlines principles that would provide a framework and foundation for oversight of MRTs, and develops recommendations to inform the Food and Drug Administration's consideration of investigational new drug applications.
Table of Contents
Front Matter
Summary
1 Introduction
2 Science and Policy Context
3 Do Ethical, Social, and Policy Considerations Preclude MRT?
4 Regulation and Oversight of MRT in Humans
Appendix A: Study Approach
Appendix B: Summary of MRT Research
Appendix C: Biosketches of Committee Members
1 Front Matter; 2 Summary; 3 1 Introduction; 4 2 Science and Policy Context; 5 3 Do Ethical, Social, and Policy Considerations Preclude MRT?; 6 4 Regulation and Oversight of MRT in Humans; 7 Appendix A: Study Approach; 8 Appendix B: Summary of MRT Research; 9 Appendix C: Biosketches of Committee Members
| Erscheinungsdatum | 05.04.2016 |
|---|---|
| Verlagsort | Washington |
| Sprache | englisch |
| Maße | 152 x 229 mm |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete |
| Studium ► 2. Studienabschnitt (Klinik) ► Humangenetik | |
| ISBN-10 | 0-309-38870-8 / 0309388708 |
| ISBN-13 | 978-0-309-38870-2 / 9780309388702 |
| Zustand | Neuware |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
An International System for Human Cytogenomic Nomenclature (2024)
Buch | Hardcover (2024)
Karger (Verlag)
CHF 119,00
Eine sehr persönliche Geschichte | Der New York Times-Bestseller
Buch | Softcover (2023)
Ullstein Taschenbuch Verlag
CHF 30,75
Buch | Softcover (2022)
John Wiley & Sons Inc (Verlag)
CHF 169,95